428 related articles for article (PubMed ID: 9410904)
1. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
Kalluri R; Danoff TM; Okada H; Neilson EG
J Clin Invest; 1997 Nov; 100(9):2263-75. PubMed ID: 9410904
[TBL] [Abstract][Full Text] [Related]
2. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
3. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen.
Abbate M; Kalluri R; Corna D; Yamaguchi N; McCluskey RT; Hudson BG; Andres G; Zoja C; Remuzzi G
Kidney Int; 1998 Nov; 54(5):1550-61. PubMed ID: 9844131
[TBL] [Abstract][Full Text] [Related]
4. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome.
Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG
J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284
[TBL] [Abstract][Full Text] [Related]
5. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
6. Human antiglomerular basement membrane autoantibody disease in XenoMouse II.
Meyers KE; Allen J; Gehret J; Jacobovits A; Gallo M; Neilson EG; Hopfer H; Kalluri R; Madaio MP
Kidney Int; 2002 May; 61(5):1666-73. PubMed ID: 11967016
[TBL] [Abstract][Full Text] [Related]
7. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice.
Hopfer H; Maron R; Butzmann U; Helmchen U; Weiner HL; Kalluri R
FASEB J; 2003 May; 17(8):860-8. PubMed ID: 12724345
[TBL] [Abstract][Full Text] [Related]
8. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
10. Identification of a nephritogenic immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis.
Reynolds J; Haxby J; Juggapah JK; Evans DJ; Pusey CD
Clin Exp Immunol; 2009 Feb; 155(2):311-9. PubMed ID: 19040602
[TBL] [Abstract][Full Text] [Related]
11. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
Thorner PS; Baumal R; Eddy A; Marrano P
Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
14. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
15. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen.
Sado Y; Boutaud A; Kagawa M; Naito I; Ninomiya Y; Hudson BG
Kidney Int; 1998 Mar; 53(3):664-71. PubMed ID: 9507212
[TBL] [Abstract][Full Text] [Related]
16. Human Goodpasture anti-alpha3(IV)NC1 autoantibodies share structural determinants.
Meyers KE; Kinniry PA; Kalluri R; Neilson EG; Madaio MP
Kidney Int; 1998 Feb; 53(2):402-7. PubMed ID: 9461099
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers.
Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB
J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish to humans: evolution of the alpha3-chain of type IV collagen and emergence of the autoimmune epitopes associated with Goodpasture syndrome.
MacDonald BA; Sund M; Grant MA; Pfaff KL; Holthaus K; Zon LI; Kalluri R
Blood; 2006 Mar; 107(5):1908-15. PubMed ID: 16254142
[TBL] [Abstract][Full Text] [Related]
19. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen.
Kalluri R; Sun MJ; Hudson BG; Neilson EG
J Biol Chem; 1996 Apr; 271(15):9062-8. PubMed ID: 8621555
[TBL] [Abstract][Full Text] [Related]
20. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
